Richard Buus

11PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersMolecular targetsLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 26, 2022
Dynamic Changes in the NK-, Neutrophil-, and B-cell Immunophenotypes Relevant in High Metastatic Risk Post Neoadjuvant Chemotherapy-Resistant Early Breast Cancers.

Patrycja Gazinska, Charlotte Milton, Jacopo Iacovacci

|Feb 13, 2021
Development and validation for research assessment of Oncotype DX® Breast Recurrence Score, EndoPredict® and Prosigna®.

Richard Buus, Zsolt Szijgyarto, Eugene F Schuster

|Oct 27, 2020
Molecular Drivers of Oncotype DX, Prosigna, EndoPredict, and the Breast Cancer Index: A TransATAC Study.

Richard Buus, Ivana Sestak, Ralf Kronenwett

|Jun 21, 2020
Prognostic Value of EndoPredict in Women with Hormone Receptor-Positive, HER2-Negative Invasive Lobular Breast Cancer.

Ivana Sestak, Martin Filipits, Richard Buus

|Nov 23, 2019
Real-time ex vivo perfusion of human lymph nodes invaded by cancer (REPLICANT): a feasibility study.

Rachel Barrow-McGee, Julia Procter, Julie Owen

Pageof 2